X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-18
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs695349-   
Low Rs400252-   
Sales per share (Unadj.) Rs260.2104.0-  
Earnings per share (Unadj.) Rs19.0-26.2-  
Cash flow per share (Unadj.) Rs33.1-21.7-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs213.081.6-  
Shares outstanding (eoy) m126.20168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.9 72.8%   
Avg P/E ratio x28.9-11.5 -251.4%  
P/CF ratio (eoy) x16.6-13.9 -119.6%  
Price / Book Value ratio x2.63.7 69.7%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m69,12050,764 136.2%   
No. of employees `00013.34.3 308.7%   
Total wages/salary Rs m7,3593,186 231.0%   
Avg. sales/employee Rs Th2,477.44,086.8 60.6%   
Avg. wages/employee Rs Th555.2742.1 74.8%   
Avg. net profit/employee Rs Th180.6-1,029.8 -17.5%   
INCOME DATA
Net Sales Rs m32,83617,545 187.2%  
Other income Rs m418123 340.2%   
Total revenues Rs m33,25417,668 188.2%   
Gross profit Rs m4,505-3,040 -148.2%  
Depreciation Rs m1,777757 234.7%   
Interest Rs m240475 50.5%   
Profit before tax Rs m2,905-4,150 -70.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m511259 197.1%   
Profit after tax Rs m2,394-4,421 -54.2%  
Gross profit margin %13.7-17.3 -79.2%  
Effective tax rate %17.6-6.2 -281.5%   
Net profit margin %7.3-25.2 -28.9%  
BALANCE SHEET DATA
Current assets Rs m19,45512,850 151.4%   
Current liabilities Rs m10,0767,230 139.4%   
Net working cap to sales %28.632.0 89.2%  
Current ratio x1.91.8 108.6%  
Inventory Days Days98111 88.3%  
Debtors Days Days67124 54.0%  
Net fixed assets Rs m20,2607,490 270.5%   
Share capital Rs m25281 309.9%   
"Free" reserves Rs m26,6330-   
Net worth Rs m26,88613,771 195.2%   
Long term debt Rs m2,3404,839 48.4%   
Total assets Rs m41,17326,014 158.3%  
Interest coverage x13.1-7.7 -169.4%   
Debt to equity ratio x0.10.4 24.8%  
Sales to assets ratio x0.80.7 118.2%   
Return on assets %6.4-15.2 -42.2%  
Return on equity %8.9-32.1 -27.7%  
Return on capital %10.8-19.8 -54.3%  
Exports to sales %47.60-   
Imports to sales %14.90-   
Net fx Rs m10,7590-   
CASH FLOW
From Operations Rs m3,4111,498 227.8%  
From Investments Rs m-1,354-460 294.5%  
From Financial Activity Rs m-1,3044,392 -29.7%  
Net Cashflow Rs m7535,430 13.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.82 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: SHASUN PHARMA  NATCO PHARMA  GLENMARK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

Sensex Ends 623 Points Higher; Realty and Telecom Stocks Witness Buying(Closing)

Indian share markets ended their day on a strong note today after BJP led NDA government got clear mandate in the Lok Sabha Election 2019.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


May 24, 2019 03:33 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS